Cigna Investments’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-13,445
Closed -$1.13M 712
2019
Q1
$1.13M Buy
13,445
+9,466
+238% +$988K 0.12% 207
2018
Q4
$469K Sell
3,979
-757
-16% -$87.5K 0.04% 352
2018
Q3
$554K Sell
4,736
-8,246
-64% -$1.02M 0.04% 335
2018
Q2
$1.5M Buy
+12,982
New +$1.42M 0.11% 164
2017
Q3
Sell
-3,637
Closed -$233K 916
2017
Q2
$233K Buy
+3,637
New +$224K 0.02% 724

Other funds holding USNA

Cigna Investments's USNA Position: Q2 2019 in Review

Cigna Investments sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 13,445 shares — an estimated $1.13M sold.

Cigna Investments first reported a position in USNA in Q2 2017 and held it in 5 quarters. The position peaked at $1.5M in Q2 2018. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

  • Cigna Investments reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
  • Cigna Investments sold 13,445 Usana Health Sciences shares in Q2 2019, an estimated $1.13M.
  • Cigna Investments first reported a position in Usana Health Sciences in Q2 2017 and held it in 5 quarters.
  • Cigna Investments's Usana Health Sciences position peaked at $1.5M in Q2 2018.
  • 173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Cigna Investments's 13F filing for Q2 2019, filed 12 Aug 2019.